234 related articles for article (PubMed ID: 25788426)
1. The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.
Pereira Wde F; Brito-Melo GE; de Almeida CA; Moreira LL; Cordeiro CW; Carvalho TG; Mateo EC; Simões E Silva AC
Inflamm Res; 2015 May; 64(5):287-301. PubMed ID: 25788426
[TBL] [Abstract][Full Text] [Related]
2. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
3. The pregnancy coexisting with experimentally induced nephrotic syndrome (NS) in rats--the histological assessment of kidneys in light microscopy.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):225-31. PubMed ID: 16145985
[TBL] [Abstract][Full Text] [Related]
4. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
5. Nephrotic syndrome (NS) and pregnancy in rat--evaluation of kidney in electron microscopy.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):220-4. PubMed ID: 16145984
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
[TBL] [Abstract][Full Text] [Related]
7. Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin.
Bohnert BN; Artunc F
J Vis Exp; 2018 May; (135):. PubMed ID: 29782000
[TBL] [Abstract][Full Text] [Related]
8. Curcumin, as a pleiotropic agent, improves doxorubicin-induced nephrotic syndrome in rats.
Fan HY; Wang XK; Li X; Ji K; Du SH; Liu Y; Kong LL; Xu JC; Yang GQ; Chen DQ; Qi D
J Ethnopharmacol; 2020 Mar; 250():112502. PubMed ID: 31881321
[TBL] [Abstract][Full Text] [Related]
9. Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome.
Ozkorucu D; Cetin N; Sav NM; Yildiz B
Int Urol Nephrol; 2016 Jul; 48(7):1187-96. PubMed ID: 26922067
[TBL] [Abstract][Full Text] [Related]
10. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
11. [Experiment study of adriamycin-induced nephrotic syndrome in rats].
Wang Z; Wang Z; Liu Z; Tan Y
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(4):430-2. PubMed ID: 2094645
[TBL] [Abstract][Full Text] [Related]
12. Effect of high-lipid diet on glomerular mesangial matrix in adriamycin-induced nephrotic rats.
Song H; Li X; Wei M; Zhu C
Chin Med Sci J; 2002 Sep; 17(3):134-9. PubMed ID: 12901534
[TBL] [Abstract][Full Text] [Related]
13. α-asarone reduce proteinuria by restoring antioxidant enzymes activities and regulating necrosis factor κB signaling pathway in doxorubicin-induced nephrotic syndrome.
Sutariya B; Saraf M
Biomed Pharmacother; 2018 Feb; 98():318-324. PubMed ID: 29274588
[TBL] [Abstract][Full Text] [Related]
14. Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome.
Ramadan R; Faour D; Awad H; Khateeb E; Cohen R; Yahia A; Torgovicky R; Cohen R; Lazari D; Kawachi H; Abassi Z
Nephrol Dial Transplant; 2012 Jun; 27(6):2231-41. PubMed ID: 22036940
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
16. Treatment of experimental nephrotic syndrome with artesunate.
Razavi A; Nouri HR; Mehrabian F; Mirshafiey A
Int J Toxicol; 2007; 26(4):373-80. PubMed ID: 17661229
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model.
Yilmaz MI; Korkmaz A; Kaya A; Sonmez A; Caglar K; Topal T; Eyileten T; Yenicesu M; Acikel C; Oter S; Yaman H; Aktug H; Oguz Y; Vural A; Ikizler TA
Nephron Exp Nephrol; 2006; 104(1):e15-22. PubMed ID: 16699289
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats.
Bi X; Zhu G; Han Z; Ye Y; Liang Y; Zhang L; Hao Z; Zeng G; He H; Zhong W
Clin Invest Med; 2009 Jun; 32(3):E229-38. PubMed ID: 19480741
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin nephropathy in severe combined immunodeficient (SCID) mice.
Lee VW; Wang Y; Qin X; Wang Y; Zheng G; Mahajan D; Coombes J; Rangan G; Alexander SI; Harris DC
Nephrol Dial Transplant; 2006 Nov; 21(11):3293-8. PubMed ID: 16891644
[No Abstract] [Full Text] [Related]
20. L-carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats.
Boonsanit D; Kanchanapangka S; Buranakarl C
Nephrology (Carlton); 2006 Aug; 11(4):313-20. PubMed ID: 16889571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
